Vincent Degos

Vincent Degos

Auto-generated profile, based on publicly available information

Vincent Degos

Clinical Research Group 29, Sorbonne Université, Paris, France

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Radiology
Verified
Journal Article
Closed access
LCLydia Chougar
Lydia Chougar
NSNatalia Shor
Natalia Shor
NWNicolas Weiss
Nicolas Weiss
DGDamien Galanaud
Damien Galanaud
DLDelphine Leclercq
Delphine Leclercq
FGFor the CoCo Neurosciences Study Group
For the CoCo Neurosciences Study Group
Background This study provides a detailed imaging assessment in a large series of COVID-19 patients with neurological manifestations. Purpose To review the MRI findings associated with acute neurol...

14 December 2021 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
LPLouis Puybasset
Louis Puybasset
VPVincent Perlbarg
Vincent Perlbarg
JUJean Unrug
Jean Unrug
DCDidier Cassereau
Didier Cassereau
DGDamien Galanaud
Damien Galanaud
TIthe MRI-COMA Investigators CENTER-TBI MRI Participants and MRI Only Investigators
the MRI-COMA Investigators CENTER-TBI MRI Participants and MRI Only Investigators

Verified
Journal Article
Open access
PDF file
AJAlice Jacquens
Alice Jacquens
ENEdward J. Needham
Edward J. Needham
EZElisa Zanier
Elisa Zanier
VDVincent Degos
Vincent Degos
PGPierre Gressens
Pierre Gressens
DMDavid Krishna Menon
David Krishna Menon
Head trauma is the most common cause of disability in young adults. Known as a silent epidemic, it can cause a mosaic of symptoms, whether neurological (sensory–motor deficits), psychiatric (depressive and anxiety symptoms), or somatic (vertigo, tinnitus, phosphenes). Furthermore, cranial trauma (CT) in children presents several particularities in terms of epidemiology, mechanism, and physiopathology—notably linked to the attack of an immature organ. As in adults, head trauma in children can have lifelong repercussions and can cause social and family isolation, difficulties at school, and, later, socio-professional adversity. Improving management of the pre-hospital and rehabilitation course of these patients reduces secondary morbidity and mortality, but often not without long-term disability. One hypothesized contributor to this process is chronic neuroinflammation, which could accompany primary lesions and facilitate their development into tertiary lesions. Neuroinflammation is a complex process involving different actors such as glial cells (astrocytes, microglia, oligodendrocytes), the permeability of the blood–brain barrier, excitotoxicity, production of oxygen derivatives, cytokine release, tissue damage, and neuronal death. Several studies have investigated the effect of various treatments on the neuroinflammatory response in traumatic brain injury in vitro and in animal and human models. The aim of this review is to examine the various anti-inflammatory therapies that have been implemented.

18 June 2020 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
LCL. Chougar
L. Chougar
BMBertrand MATHON
Bertrand MATHON
NWN. Weiss
N. Weiss
VDV. Degos
V. Degos
NSN. Shor
N. Shor
SUMMARY: There is growing evidence that Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has a neurotropic and neuroinvasive potential. In particular, neurologic complications associated with the infection by SARS-CoV-2 include strokes that may result from a dysregulated inflammatory response to the infection. We report an atypical deep cerebral vein thrombosis complicated with hemorrhagic venous infarction in a patient positive for SARS-CoV-2 with no risk factors for thrombosis.

29 January 2020 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
FCFrédéric Clarençon
Frédéric Clarençon
FBFlore Baronnet
Flore Baronnet
ESEimad Shotar
Eimad Shotar
VDVincent Degos
Vincent Degos
CRClaudia Rolla‐Bigliani
Claudia Rolla‐Bigliani
NSNader‐Antoine Sourour
Nader‐Antoine Sourour
Background and purpose: The purpose of this study was to evaluate the safety and effectiveness of mechanical thrombectomy (MT) in patients with acute ischaemic stroke related to isolated and primary posterior cerebral artery (PCA) occlusions amongst the patients enrolled in the multicentre post‐market Trevo Registry.Method: Amongst the 2008 patients enrolled in the Trevo Registry with acute ischaemic stroke due to large vessel occlusion treated by MT, 22 patients (1.1%) [10 females (45.5%), mean age 66.2 ± 14.3 years (range 28–91)] had a PCA occlusion [17 P1 (77.3%) and five P2 occlusions (22.7%)]. Recanalization after the first Trevo (Stryker, Fremont, CA, USA) pass and at the end of the procedure was rated using the modified Thrombolysis in Cerebral Infarction (mTICI) score. Procedure‐related complications (i.e. groin puncture complication, perforation, symptomatic haemorrhage, embolus in a new territory) were also recorded. The modified Rankin Scale at 90 days was assessed.Results: Median National Institutes of Health Stroke Scale at admission was 14 (interquartile range 8–16). Stroke aetiology was cardio‐embolic in 68.2% of cases. Half of the patients (11/22) received intravenous tissue plasminogen activator. 54.5% of the patients were treated under general anaesthesia. Reperfusion (i.e. mTICI 2b or 3) after first pass was obtained in 65% of cases. Final mTICI 2b–3 reperfusion was obtained in all cases. Only one (4.5%) procedure‐related complication was recorded (puncture site) that resolved after surgery. At 90‐day follow‐up, modified Rankin Scale 0–2 was obtained in 59% of the patients and 9.1% died within the first 3 months after MT.Conclusion: Mechanical thrombectomy for PCA occlusions seems to be safe (<5% procedure‐related complications) and effective. Larger repository datasets are needed.

15 December 2020 in Journal of Neurotrauma
Verified
Journal Article
Closed access
APArnaud Pouvelle
Arnaud Pouvelle
GPGeoffroy Pouliquen
Geoffroy Pouliquen
KPKevin Premat
Kevin Premat
LCLydia Chougar
Lydia Chougar
SLStéphanie Lenck
Stéphanie Lenck
ESEimad Shotar
Eimad Shotar
Chronic subdural hematomas (CSDHs) are one of the most prevalent head-trauma-related conditions. The middle meningeal artery (MMA) may participate in the pathophysiology of CSDHs. The aim of this study was to determine whether CSDHs are associated with large MMAs. Patients referred for CSDH embolization and having undergone a computed tomography angiography (CTA) before embolization were retrospectively included. For each CSDH patient, two age- and sex-matched controls with a CTA performed during the study period were selected. Size comparisons of the MMA were performed between MMAs ipsilateral to CSDHs, on the contralateral side, and in controls. Comparison was also made with angiographic measurements from CSDH embolization procedures. Seventy-five patients with CSDH with available CTAs prior to embolization were enrolled and 146 MMAs were measured. One hundred fifty controls were included and 288 MMAs were measured. The median diameter of the 94 MMAs ipsilateral to a CSDH (1.5 mm; interquartile range [IQR] 1.3–1.7) was significantly larger than that of control MMAs (1.28 mm; IQR 1.15–1.4) (p < 0.001). The median diameter of 52 MMAs on the side of a unilateral CSDH (1.6 mm; IQR 1.4–1.8) was larger than that of the 52 contralateral MMAs (1.4 mm; IQR 1.25–1.6) (p < 0.001). Among the characteristics of patients with CSDH, multiple surgeries were associated with significantly larger MMAs (>1.7 mm; p = 0.01). MMAs ipsilateral to CSDHs appear to be significantly larger as compared with contralateral MMAs and MMAs in a control population, suggesting the involvement of the MMA in the pathophysiology of CSDH.